COMBIVIR
150 / 300 MG / MG · comprime pellicule secable · box 60 tablets
LAMIVUDINE / ZIDOVUDINEReference dated : 2017-12-18. Confirm price and availability with a pharmacist.
Composition and presentation
COMBIVIR — LAMIVUDINE / ZIDOVUDINE. Listed presentation: 150 / 300 MG / MG · COMPRIME PELLICULE SECABLE · 1 BOITE 60 COMPRIME.
Full clinical reference
Additional sections are available in French. Read the original document; the information concerns the French reference product.
Uses
LAMIVUDINE/ZIDOVUDINE ARROW is indicated as part of antiretroviral combinations for the treatment of Human Immunodeficiency Virus (HIV) infection (see section 4.2).
Driving
No study is available concerning the effects of lamivudine/zidovudine on the ability to drive vehicles and use machines.
Hospital price
2.140,00 MAD
Type
Originator
References and update dates
CNOPS Referentiel des medicaments · 2017-12-18
Product and price referenceThis information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: Not available in the verified source
Referenced presentations and strengths
Other strengths and forms
Routes and instructions may differ.
- AVOCOMB · 150 / 300 MG / MG · film-coated tablet · box 60 tablets
- AVOCOMB · 150 / 300 MG / MG · film-coated tablet · box 60 tablets
- AVOCOMB · 150 MG / 300 MG · film-coated tablet · box of 60
- DUOVIR · 150 / 300 MG / MG · film-coated tablet · box 60 tablets
- DUOVIR · 150 MG / 300 MG · film-coated tablet · box of 60